Population and Public Health

FDA Approves Imaavy as First Therapy for Rare Blood Disorder
Care FDA Approves Imaavy as First Therapy for Rare Blood Disorder

While corticosteroids have been the standard of care for decades, their long-term use is associated with severe side effects like bone density loss, weight gain, and metabolic disturbances. This reality has defined the lives of many living with warm autoimmune hemolytic anemia (wAIHA), a condition

Empathy and Trust Are Key to Addressing Vaccine Hesitancy
Care Empathy and Trust Are Key to Addressing Vaccine Hesitancy

Addressing vaccine hesitancy requires a shift in focus from simply convincing parents to understanding the human emotions behind their medical decisions. In the current medical landscape, the relationship between healthcare providers and families has become increasingly strained as pediatric

Can New Tools Help Pennsylvania Stop the Measles Outbreak?
Care Can New Tools Help Pennsylvania Stop the Measles Outbreak?

The resurgence of measles in Pennsylvania has transformed from a localized concern into a significant test of the state’s modern public health infrastructure and its ability to safeguard the youngest citizens. As school systems prepare for the current academic cycle, the persistence of nearly 300 c

Patient Financing Integrates Into the Digital Front Door
Care Patient Financing Integrates Into the Digital Front Door

Faisal Zain is a cornerstone of the healthcare technology landscape, bringing decades of specialized expertise in medical diagnostics and the manufacturing of treatment devices. Throughout his career, he has observed a frustrating paradox: while we have mastered the art of high-tech clinical

Is Laser Cataract Surgery a Necessity or a Revenue Driver?
Business Is Laser Cataract Surgery a Necessity or a Revenue Driver?

A quiet tension often unfolds in modern ophthalmology clinics as patients weigh the choice between a standard, insurance-covered procedure and a high-tech laser alternative that costs thousands of dollars out of pocket. For decades, the manual removal of cataracts was a straightforward medical

Is Medicare’s GLP-1 Bridge Program Helping or Hurting?
Care Is Medicare’s GLP-1 Bridge Program Helping or Hurting?

The exclusion of patients whose conditions are already FDA-approved for GLP-1 treatment highlights a significant friction point in federal healthcare policy. For decades, the federal government maintained a rigid statutory wall that prevented Medicare from covering medications prescribed solely for

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later